actively transported from the liver to the bile though it is extensively metabolized to large polar fragments. After oral ingestion 15~18 % of the administrated factor Mt was absorbed through the gastro-intestinal tract. Neither bile nor the lymphatic system seemed to play a role in that absorption. The experimental data emphasized the importance of the plasmatic compartment as a reservoir for the antibiotic, the rapidity of tissular fixation and the special affinity of the factor Mxfor the skin. They correlated very well with the clinical trials which revealed the efficiency of the drug in the treatment of the gram-positive bacterial infections and the rapid onset of its action.
Virginiamycin is an antibiotic produced by a strain of Streptomyces virginiaeî solated in 1954 by DeSomer and VanDijck9). By its physicochemical properties and its antimicrobial spectrum it belongs to the family of streptogramin19). In the crude antibiotic, two groups of substances have been identified: the group of factors M or "micrococcus" factors and the one of factors S or "bacillus subtilis" factors13).
They show a definite synergistic action. Factors of the group S significantly enhance the potency of factors M, in vitro as well as in vivo.
Most of the antimicrobial activity of virginiamycin is due to factor Mj which is also quantitatively the main component. Its chemical structure appears very similar if not identical to ostreogrycin A7>8), a macrocyclic unsaturated lactone containing an oxazole ring. Gram-positive bacteria, Neisseria gonorrhoeae and Hemophilus pertussis are sensitive to the bacteriostatic effect of factor Mi with factor S. This antimicrobial action seems to be related to a blockade of the protein biosynthesis at the ribosomal site11*12).
The present publication reports the pattern of absorption, tissue distribution and elimination of the antibiotic in the rat after oral and parenteral administration. Some correlations are madebetween the results obtained with the two modesof administration. Amour and Blood (1963) . In order to minimize the physiological disturbances resulting from the interruption of the enterohepatic cycle, the bile was never collected over more than 3hours4). During this period of time the mean value of the measured biliary flow remained constant and reached 42mg/min./kg. The lymph was obtained from the thoracic duct according to the technique reported by Boliman et al2).
As previously described155, factor Mi was injected into the femoral vein at a dose of 1mg/kgas a plasmatic solution or administrated per os as an aqueous suspension at a dose of 3mg/kg by means of a gastric tubing without anesthesia.
The radioactivity of the samples was measured by liquid scintillation counting after combustion in a Parr bomb or a Schoniger flask, hyamine digestion or direct dissolution in the solvent-scintillators system. Counting efficiency was determined using n-hexadecane
Chromatographic analysis of factor Mxand of the bile extracts were carried out by thin-layer chromatography. (Adsorbent: silical gel HRand HF254: "Merck"; solvent CH2C12-CH3OH 9/1 V/V13>).
The antibiotic was assayed spectrophotometrically after reaction at 70°C in 2.5N HC1 with Erhlich reagent18)).
A quaternary ammonium compoundof general structure
Clwas used at a dose of 2mg/ml bile to destroy its micellar structure.
The reverse isotopic dilution method applied to the bile samples was essentially identical to that previously described for plasma16). The confidence limits of the curves presented in this paper were calculated according to the equation
Pure and crystallized factor Mx was kindly supplied by RIT Laboratories, Belgium. Radioactive compounds were prepared either by biological synthesis using UClabelled After oral administration or intravenous injection, the tritiated and/or 14Glabelled factor Mi was rapidly absorbed or diluted. Radioactivity present in the blood after both i.ngestion and injection was located for its major part (respectively 80 % and 90 %) in the plasmatic compartment where it was distributed between a protein bound (75 %) and a free (25%) fraction. This latter part of the radioactivity was identified as unmetabolized factor Mi16).
The absorbed or diluted radioactivity disappeared from the plasma stream at a first order exponential rate with a half life of approximately 5hours (Fig. 1 ).
Excretion from the body
The bile was the main route by which the antibiotic was excreted from the body. During the first hours following the oral administration the radioactive bile concentration (Gb) was high and reached between 15 to 25/ig/ml and from the given 0.75mg dose, 30jug were excreted between 0 and 3hours (Table 1) . Three hours after intravenous injection 20% of the dose was already found in the intestine and/or the caecum15).
The rate of decline of factor Mx concentration in the bile has been studied over a 2-hour period. During this interval the bile outflow remained unchanged. The variance analysis of the logarithmically transformed data (5 experiments) showed two linear regressions (Fig. 2) . On the other hand, the elimination by the kidney was low, the radioactivity in the uring (Gu) corresponded to a concentration of factor Mi less than 1jug/ml for th first 6hours after oral administra tion.
The total excreted amount ii 24hours
did not exceed what wa found in the bile 3hours after th ingestion.
Following the intravenou injection, the urinary excretion wa less than 10% in 24hours15).
3. Distribution in tissues
While being excreted by the bil and the urine, the factor Mx wa taken up by the rat's tissues (Fig. 3) All the tissues were involved. Th liver (3.4ug/g)y the skin (1.4uglg) the small intestine (1. 7/ig/g) and th< kidneys (1.4juglg) showed howeve a real selective affinity by comparisoi with the other tissues whose value ranged from 0.2 to 0.3Mglg-The fixation was a rapid pheno menon which appeared to be reversi ble. After 40minutes maximumcon centration was reached most of th« times. Muscle concentration (0.1< Uglg) was practically identical whatever the route of administration.
B. Route and Efficiency of the Oral Absorption
After oral administration, the highest radioactive blood concentration was so rapidly reached that it seemed important to search for the participation of the gastric mucosa in the absorption of the antibiotic. At the same time, taking into account the well-known factor Mj chemical reactivity at acidic pH in vitro analysis of the extracts from the gastric juices was also carried out.
Finally, the lipid-soluble character of factor Mxshould suggest that its intestinal absorption, if any, might be influenced by the bile or might occur through the lymphatic system. Those two parameters were also investigated. 1. The stomachic absorption and the stability in the gastric juice.
The orally administered factor Mx was artificially either maintained in the stomach up to 160minutes by ligation of the duodenum or deviated from the intestine by insertion of a cannula into the stomachic cavity through the pylorus. The radioactive plasmatic (Gp) and biliary (Gb) concentrations were measured at various times after the ingestion.
The results presented in Table 2 showed the presence or radioactive material in both plasma and bile samples. They clearly indicated a real but probably minor role, in more physiological conditions, of the stomachic mucosa in the absorption of the antibiotic. The radiochromatographic analysis as well as the chemical assay of The radioactive lymph concentrations (Cl) were always much lower than the corresponding blood levels, which would indicate the secondary, if any, role of this system in the antibiotic absorption (Table 4) . Meanvalues from last 4experiments±s.e.
Only 8-9% of the total radioactivity corresponded to the factor Mxwhich represented approximately 20% of the total extracted labelleds compounds. None of the applied treatments enhanced this percentage (Table 7) .
Discussion
Whatever the route of administration of the labelled factor Mu the angular coefficient and the period for the plasma elimination curves (cf. ± mean valuesis.e.t0,10 1) were very similar if not identical (Table  8 ). In both cases the bile played the preponderant role in the elimination of drug and the antibiotic was simultaneously taken up by the tissues in a reversible step.
With the equations reported in Figs. 1 and 2 representing respectively the kinetics of factor Mj plasmatic elimination and biliary excretion it was possible to calculate the theoretical plasmatic (Cp) and biliary (Cb) concentrations in terms of radioactivity at various times after the intravenous injection of factor Mxat a dose of 1mg/kg. Taking into account the fact that the plasmatic free fraction corresponded essentially to the unchanged drug16) and that 8-9% of the radioactivity excreted in the bile was due to non-metabolized molecules, it was also possible to calculate the (CbMi) and (CpM^values for Factor Mx. The Cb/Cp and CbMx/CpMj ratios times the value of biliary flow (mean measured value : 0.042g/kg) gave an estimate of the excretion rate as a "biliary clearance" as denned by Cook et al.5) i.e. "the plasma volume containing the amount of factor M! excreted per minute". In the present case, we observed indeed (cf. Fig. 1 ) that there was practically no latency between the time of injection and the first appearance in the bile. Moreover, the biliary concentration (cf. Fig. 2 ) reached its maximumat the earliest collection period and fell logarithmically thereafter.
In terms of total radioactivity the ratio Cb/Cp was in favor of the bile for all the period of time explored.
On the other hand the CbMi/CpMj ratio, high at the beginning, decreased rapidly to a near unit value.
In both cases the excretion rate slowed down with time.
After oral administration the values of Cb/Cp and Forty minutes after oral administration the factor Mxplasmatic free concentration reaches 0.6 to 0.7jugIml and after intravenous injection around 2.0//g/ml.
At the same time the average tissue levels are respectively 0.6 and 1.2jug/g.
In connection with our present results, the clinical trials reveal the efficiency of the drug in the treatment of the Gram-positive bacterial infections and the rapid onset of its action.
Among all the reported cases it is interesting to emphasize in particular the great utility of the per os treatment against cutaneous infections1*2^or septicemiae.
All those observations might be interpreted in terms of the importance of the plasmatic compartmentas a reservoir for the antibiotic, the rapidity of tissue fixation and the special affinity of the factor Mxfor the skin. 
